Pediatric ALL Protocols Have Low Risk of Late Effects

Long-term outcomes of patients treated for pediatric acute lymphoblastic leukemia (ALL) with modern treatment protocols are good, with an overall low risk for serious long-term side effects, according to the results of report from the Childhood Cancer Survivor Study cohort.

Read more at: http://www.cancernetwork.com/hematologic-malignancies/pediatric-all-protocols-have-low-risk-late-effects#sthash.XMsdOLbI.dpuf